|
|
Other links at Articles > Business of Medicine |
| 1. |
FDA Reprimands GlaxoSmithKline Over Missing Data on Rosiglitazone
|
|
|
In a letter to GlaxoSmithKline, the FDA said that an inspection in late 2007 focusing on compliance with postmarketing adverse drug experience reporting requirements found that the company failed to report data from clinical usage and failed to disclose or submit data from clinical trials. Heartwire
|
| 3. |
U.S. Lawmakers Call on Drug Companies to Curb Ads
|
|
|
Two senior Democratic lawmakers called on several drug companies on Tuesday to voluntarily adopt a two-year moratorium on consumer-oriented advertisements for new prescription drugs. Reuters Health Information
|
|
|
